Noncoding RNAs in Host–Microbiota Interaction

Abstract

The dynamic interaction between the gut microbiota and the host significantly affects host biological processes and disease progression. In recent years, the regulatory mechanisms underlying these intricate interactions have been widely studied. Noncoding RNAs (ncRNAs) are a class of functional RNAs that, despite not being translated into proteins, play critical roles in mediating host–gut microbiota interactions. In this review, we systematically elucidate the mechanisms of action and influence of ncRNAs derived from both hosts and microorganisms. Specifically, certain host ncRNAs depend on the microbiota to modulate gene expression and function, whereas other host ncRNAs can alter the composition and functionality of the gut microbiota. Conversely, bacterial small RNAs (sRNAs) can infiltrate host cells and modulate the expression and functions of host genes. These interactions reveal the complex communication modes between the host and microbiota, providing a new perspective for investigating the occurrence and development of intestinal diseases. Consequently, through the intervention of ncRNAs, host‒microbe interaction dynamics can be effectively regulated, thereby providing potential theoretical and technical foundations for the prevention and treatment of intestinal diseases.

Keywords

gut microbe / host / interactions / noncoding RNA / sRNA

References

[1] M. Sanchez-Tapia, A. R. Tovar, and N. Torres, “Diet as Regulator of Gut Microbiota and its Role in Health and Disease,” Archives of Medical Research50, no. 5 (2019): 259-268, https://doi.org/10.1016/j.arcmed.2019.09.004.

[2] A. Nishida, R. Inoue, O. Inatomi, S. Bamba, Y. Naito, and A. Andoh, “Gut Microbiota in the Pathogenesis of Inflammatory Bowel Disease,” Journal of Clinical Gastroenterology11, no. 1 (2018): 1-10, https://doi.org/10.1007/s12328-017-0813-5.

[3] Y. Wang, X. Chen, S. A. Huws, et al., “Ileal Microbial Microbiome and Its Secondary Bile Acids Modulate Susceptibility to Nonalcoholic Steatohepatitis in Dairy Goats,” Microbiome12, no. 1 (2024): 247, https://doi.org/10.1186/s40168-024-01964-0.

[4] W. Wang, Z. Wei, Z. Li, et al., “Integrating Genome- and Transcriptome-Wide Association Studies to Uncover the Host-Microbiome Interactions in Bovine Rumen Methanogenesis,” IMETA3, no. 5 (2024), https://doi.org/10.1002/imt2.234.

[5] S. Wu, L. Zhu, T. Wang, et al., “Ocular Microbiota Types and Longitudinal Microbiota Alterations in Patients With Chronic Dacryocystitis With and Without Antibiotic Pretreatment,” iMetaOmics1 (2024), https://doi.org/10.1002/imo2.17.

[6] C. Jin, S. Wu, Z. Liang, et al., “Multi-Omics Reveal Mechanisms of High Enteral Starch Diet Mediated Colonic Dysbiosis via Microbiome-Host Interactions in Young Ruminant,” Microbiome12, no. 1 (2024): 38, https://doi.org/10.1186/s40168-024-01760-w.

[7] D. Wang, L. Chen, G. Tang, et al., “Multi-Omics Revealed the Long-Term Effect of Ruminal Keystone Bacteria and the Microbial Metabolome on Lactation Performance in Adult Dairy Goats,” Microbiome11, no. 1 (2023): 215, https://doi.org/10.1186/s40168-023-01652-5.

[8] S. Wu, L. Cheng, A. A. L. Pennhag, et al., “The Salivary Microbiota Is Altered in Cervical Dysplasia Patients and Influenced by Conization,” IMETA2, no. 3 (2023), https://doi.org/10.1002/imt2.108.

[9] B. Liu, X. Liu, Z. Liang, and J. Wang, “Gut Microbiota in Obesity,” World Journal of Gastroenterology27, no. 25 (2021): 3837-3850, https://doi.org/10.3748/wjg.v27.i25.3837.

[10] J. Ye, Z. Wu, Y. Zhao, S. Zhang, W. Liu, and Y. Su, “Role of Gut Microbiota in the Pathogenesis and Treatment of Diabetes Mullites: Advanced Research-Based Review,” Frontiers in Microbiology13 (2022), https://doi.org/10.3389/fmicb.2022.1029890.

[11] Z. Xu, N. Jiang, Y. Xiao, K. Yuan, and Z. Wang, “The Role of Gut Microbiota in Liver Regeneration,” Frontiers in Immunology13 (2022), https://doi.org/10.3389/fimmu.2022.1003376.

[12] H. Liu, J. Zhuang, P. Tang, J. Li, X. Xiong, and H. Deng, “The Role of the Gut Microbiota in Coronary Heart Disease,” Current Atherosclerosis Reports22, no. 12 (2020): 77, https://doi.org/10.1007/s11883-020-00892-2.

[13] C. Zhang, H. Liu, L. Sun, et al., “An Overview of Host-Derived Molecules That Interact With Gut Microbiota,” iMeta2, no. 2 (2023): e88, https://doi.org/10.1002/imt2.88.

[14] S. Dahariya, I. Paddibhatla, S. Kumar, S. Raghuwanshi, A. Pallepati, and R. K. Gutti, “Long Non-Coding RNA: Classification, Biogenesis and Functions in Blood Cells,” Molecular Immunology112 (2019): 82-92, https://doi.org/10.1016/j.molimm.2019.04.011.

[15] J. O’Brien, H. Hayder, Y. Zayed, and C. Peng, “Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation,” Frontiers in Endocrinology9 (2018), https://doi.org/10.3389/fendo.2018.00402.

[16] A. Francavilla, S. Turoczi, S. Tarallo, P. Vodicka, B. Pardini, and A. Naccarati, “Exosomal MicroRNAs and Other Non-Coding RNAs as Colorectal Cancer Biomarkers: A Review,” Mutagenesis35, no. 3 (2020): 243-260, https://doi.org/10.1093/mutage/gez038.

[17] A. Kilikevicius, G. Meister, and D. R. Corey, “Reexamining Assumptions About miRNA-Guided Gene Silencing,” Nucleic Acids Research50, no. 2 (2022): 617-634, https://doi.org/10.1093/nar/gkab1256.

[18] C. Zhang, H. Liu, X. Jiang, et al., “An Integrated Microbiome- and Metabolome-Genome-Wide Association Study Reveals the Role of Heritable Ruminal Microbial Carbohydrate Metabolism in Lactation Performance in Holstein Dairy Cows,” Microbiome12, no. 1 (2024): 232, https://doi.org/10.1186/s40168-024-01937-3.

[19] Z. Cheng, L. Yang, and H. Chu, “The Role of Gut Microbiota, Exosomes, and Their Interaction in the Pathogenesis of ALD,” Journal of Advanced Research (2024), https://doi.org/10.1016/j.jare.2024.07.002.

[20] Y. A. Chen and A. A. Aravin, “Non-Coding RNAs in Transcriptional Regulation: The Review for Current Molecular Biology Reports,” Current Molecular Biology Reports1, no. 1 (2015): 10-18, https://doi.org/10.1007/s40610-015-0002-6.

[21] R. Shang, S. Lee, G. Senavirathne, and E. C. Lai, “microRNAs in Action: Biogenesis, Function and Regulation,” Nature Reviews Genetics24, no. 12 (2023): 816-833, https://doi.org/10.1038/s41576-023-00611-y.

[22] S. R. Liu, A. P. Da Cunha, R. M. Rezende, et al., “The Host Shapes the Gut Microbiota via Fecal MicroRNA,” Cell Host & Microbe19, no. 1 (2016): 32-43, https://doi.org/10.1016/j.chom.2015.12.005.

[23] A. T. Filip, O. Balacescu, C. Marian, and A. Anghel, “Microbiota Small RNAs in Inflammatory Bowel Disease,” Journal of Gastrointestinal and Liver Diseases25, no. 4 (2016): 509-516, https://doi.org/10.15403/jgld.2014.1121.254.lip.

[24] J. M. Allaire, S. M. Crowley, H. T. Law, S. Chang, H. Ko, and B. A. Vallance, “The Intestinal Epithelium: Central Coordinator of Mucosal Immunity,” Trends in Immunology39, no. 9 (2018): 677-696, https://doi.org/10.1016/j.it.2018.04.002.

[25] P. Louis, G. L. Hold, and H. J. Flint, “The Gut Microbiota, Bacterial Metabolites and Colorectal Cancer,” Nature Reviews Microbiology12, no. 10 (2014): 661-672, https://doi.org/10.1038/nrmicro3344.

[26] M. Bezzi, J. Guarnerio, and P. P. Pandolfi, “A Circular Twist on microRNA Regulation,” Cell Research27, no. 12 (2017): 1401-1402, https://doi.org/10.1038/cr.2017.136.

[27] W. Zhou, Z. Cai, J. Liu, D. Wang, H. Ju, and R. Xu, “Circular RNA: Metabolism, Functions and Interactions With Proteins,” Molecular Cancer19, no. 1 (2020): 172, https://doi.org/10.1186/s12943-020-01286-3.

[28] K. Liu, Y. Guo, K. Zheng, et al., “Identification of the circRNA-miRNA-mRNA Regulatory Network of Hsp90 Inhibitor-Induced Cell Death in Colorectal Cancer by Integrated Analysis,” Gene727 (2020): 144232, https://doi.org/10.1016/j.gene.2019.144232.

[29] C. P. Ponting, P. L. Oliver, and W. Reik, “Evolution and Functions of Long Noncoding RNAs,” Cell136, no. 4 (2009): 629-641, https://doi.org/10.1016/j.cell.2009.02.006.

[30] J. M. Engreitz, N. Ollikainen, and M. Guttman, “Long Non-Coding RNAs: Spatial Amplifiers That Control Nuclear Structure and Gene Expression,” Nature Reviews Molecular Cell Biology17, no. 12 (2016): 756-770, https://doi.org/10.1038/nrm.2016.126.

[31] H. Ma, T. Hu, W. Tao, et al., “A lncRNA From an Inflammatory Bowel Disease Risk Locus Maintains Intestinal Host-Commensal Homeostasis,” Cell Research33, no. 5 (2023): 372-388, https://doi.org/10.1038/s41422-023-00790-7.

[32] M. Pagliari, F. Munari, M. Toffoletto, et al., “Helicobacter pylori Affects the Antigen Presentation Activity of Macrophages Modulating the Expression of the Immune Receptor CD300E Through miR-4270,” Frontiers in Immunology8 (2017), https://doi.org/10.3389/fimmu.2017.01288.

[33] S. K. Sahu, M. Kumar, S. Chakraborty, et al., “MicroRNA 26a (miR-26a)/KLF4 and CREB-C/EBPβ Regulate Innate Immune Signaling, the Polarization of Macrophages and the Trafficking of Mycobacterium tuberculosis to Lysosomes During Infection,” PLoS Pathogens13, no. 5 (2017): e1006410, https://doi.org/10.1371/journal.ppat.1006410.

[34] R. Kumar, S. K. Sahu, M. Kumar, et al., “MicroRNA 17-5p Regulates Autophagy in Mycobacterium Tuberculosis-Infected Macrophages by Targeting Mcl-1 and STAT3,” Cellular Microbiology18, no. 5 (2016): 679-691, https://doi.org/10.1111/cmi.12540.

[35] M. Kumar, S. K. Sahu, R. Kumar, et al., “MicroRNA Let-7 Modulates the Immune Response to Mycobacterium tuberculosis Infection via Control of A20, an Inhibitor of the NF-κB Pathway,” Cell Host & Microbe17, no. 3 (2015): 345-356, https://doi.org/10.1016/j.chom.2015.01.007.

[36] J. Zhang, N. Zhang, W. Wu, et al., “MicroRNA-24 Modulates Staphylococcus Aureus-Induced Macrophage Polarization by Suppressing CHI3L1,” Inflammation40, no. 3 (2017): 995-1005, https://doi.org/10.1007/s10753-017-0543-3.

[37] C. Maudet, M. Mano, U. Sunkavalli, et al., “Functional High-Throughput Screening Identifies the miR-15 microRNA Family as Cellular Restriction Factors for Salmonella Infection,” Nature Communications5, no. 1 (2014): 4718, https://doi.org/10.1038/ncomms5718.

[38] B. C. Roy, D. Subramaniam, I. Ahmed, et al., “Role of Bacterial Infection in the Epigenetic Regulation of Wnt Antagonist WIF1 by PRC2 Protein EZH2,” Oncogene34, no. 34 (2015): 4519-4530, https://doi.org/10.1038/onc.2014.386.

[39] Y. Xiao, X. Dai, K. Li, G. Gui, J. Liu, and H. Yang, “Clostridium Butyricum Partially Regulates the Development of Colitis-Associated Cancer Through miR-200c,” Cellular and Molecular Biology63, no. 4 (2017): 59-66, https://doi.org/10.14715/cmb/2017.63.4.10.

[40] Z. Zhu, J. Huang, X. Li, et al., “Gut Microbiota Regulate Tumor Metastasis via circRNA/miRNA Networks,” Gut Microbes12, no. 1 (2020): 1788891, https://doi.org/10.1080/19490976.2020.1788891.

[41] X. Zhou, G. Xu, C. Yin, W. Jin, and G. Zhang, “Down-Regulation of miR-203 Induced by Helicobacter pylori Infection Promotes the Proliferation and Invasion of Gastric Cancer by Targeting CASK,” Oncotarget5, no. 22 (2014): 11631-11640, https://doi.org/10.18632/oncotarget.2600.

[42] X. Zhou, L. Li, J. Su, and G. Zhang, “Decreased miR-204 in H. pylori-Associated Gastric Cancer Promotes Cancer Cell Proliferation and Invasion by Targeting SOX4 (Retracted Article),” PLoS One9, no. 7 (2014): e101457, https://doi.org/10.1371/journal.pone.0101457.

[43] J. M. Noto, M. B. Piazuelo, R. Chaturvedi, et al., “Strain-Specific Suppression of microRNA-320 by Carcinogenic Helicobacter pylori Promotes Expression of the Antiapoptotic Protein Mcl-1,” American Journal of Physiology - Gastrointestinal and Liver Physiology305, no. 11 (2013): G786-G796, https://doi.org/10.1152/ajpgi.00279.2013.

[44] G. Teng, Y. Dai, Y. Chu, et al., “Helicobacter pylori Induces Caudal-Type Homeobox Protein 2 and Cyclooxygenase 2 Expression by Modulating microRNAs in Esophageal Epithelial Cells,” Cancer Science109, no. 2 (2018): 297-307, https://doi.org/10.1111/cas.13462.

[45] K. Nakata, Y. Sugi, H. Narabayashi, et al., “Commensal Microbiota-Induced microRNA Modulates Intestinal Epithelial Permeability Through the Small GTPase ARF4,” Journal of Biological Chemistry292, no. 37 (2017): 15426-15433, https://doi.org/10.1074/jbc.m117.788596.

[46] Y. Xu, L. Zhu, B. Hu, et al., “A New Expression Plasmid in Bifidobacterium longum as a Delivery System of Endostatin for Cancer Gene Therapy,” Cancer Gene Therapy14, no. 2 (2007): 151-155, https://doi.org/10.1038/sj.cgt.7701003.

[47] F. J. Sheedy, E. Palsson-McDermott, E. J. Hennessy, et al., “Negative Regulation of TLR4 via Targeting of the Proinflammatory Tumor Suppressor PDCD4 by the microRNA miR-21,” Nature Immunology11, no. 2 (2010): 141-159, https://doi.org/10.1038/ni.1828.

[48] Y. Zhu and H. Zhang, “Research Progress of Non-Coding RNA Tuberculosis. Chinese,” Journal of Antituberculosis44, no. 12 (2022): 1358-1362.

[49] L. Giahi, E. Aumueller, I. Elmadfa, and A. G. Haslberger, “Regulation of TLR4, P38 MAPkinase, IκB and miRNAs by Inactivated Strains of Lactobacilli in Human Dendritic Cells,” Beneficial Microbes3, no. 2 (2012): 91-98, https://doi.org/10.3920/bm2011.0052.

[50] L. M. Holdt, A. Kohlmaier, and D. Teupser, “Circular RNAs as Therapeutic Agents and Targets,” Frontiers in Physiology9 (2018), https://doi.org/10.3389/fphys.2018.01262.

[51] Y. Xiang, L. Kuai, Y. Ru, et al., “Transcriptional Profiling and circRNA-miRNA-mRNA Network Analysis Identify the Biomarkers in Sheng-ji Hua-yu Formula Treated Diabetic Wound Healing,” Journal of Ethnopharmacology268 (2021): 113643, https://doi.org/10.1016/j.jep.2020.113643.

[52] Y. Zhang, C. Jia, and C. K. Kwoh, “Predicting the Interaction Biomolecule Types for lncRNA: An Ensemble Deep Learning Approach,” Briefings in Bioinformatics22, no. 4 (2021), https://doi.org/10.1093/bib/bbaa228.

[53] F. Jiang, J. Lou, X. Zheng, and X. Yang, “LncRNA MIAT Regulates Autophagy and Apoptosis of Macrophage Infected by Mycobacterium Tuberculosis Through the miR-665/ULK1 Signaling axis,” Molecular Immunology139 (2021): 42-49, https://doi.org/10.1016/j.molimm.2021.07.023.

[54] H. Bai, Q. Wu, X. Hu, et al., “Clinical Significance of lnc-AC145676.2.1-6 and lnc-TGS1-1 and Their Variants in Western Chinese Tuberculosis Patients,” International Journal of Infectious Diseases84 (2019): 8-14, https://doi.org/10.1016/j.ijid.2019.04.018.

[55] J. Wang, Z. Liu, Y. Xu, et al., “Enterobacterial LPS-Inducible LINC00152 Is Regulated by Histone Lactylation and Promotes Cancer Cells Invasion and Migration,” Frontiers in Cellular and Infection Microbiology12 (2022): 913815, https://doi.org/10.3389/fcimb.2022.913815.

[56] Y. Wang, M. Wang, J. Chen, et al., “The Gut Microbiota Reprograms Intestinal Lipid Metabolism Through Long Noncoding RNA Snhg9,” Science381, no. 6660 (2023): 851-857, https://doi.org/10.1126/science.ade0522.

[57] J. Hong, F. Guo, S. Y. Lu, et al., “Nucleatum Targets lncRNA ENO1-IT1 to Promote Glycolysis and Oncogenesis in Colorectal Cancer,” Gut70, no. 11 (2021): 2123-2137, https://doi.org/10.1136/gutjnl-2020-322780.

[58] C. Maudet, M. Mano, and A. Eulalio, “MicroRNAs in the Interaction Between Host and Bacterial Pathogens,” FEBS Letters588, no. 22 (2014): 4140-4147, https://doi.org/10.1016/j.febslet.2014.08.002.

[59] B. C. E. Peck, A. T. Mah, W. A. Pitman, S. Ding, P. K. Lund, and P. Sethupathy, “Functional Transcriptomics in Diverse Intestinal Epithelial Cell Types Reveals Robust MicroRNA Sensitivity in Intestinal Stem Cells to Microbial Status,” Journal of Biological Chemistry292, no. 7 (2017): 2586-2600, https://doi.org/10.1074/jbc.m116.770099.

[60] L. He, X. Zhou, Y. Liu, L. Zhou, and F. Li, “Fecal miR-142a-3p From Dextran Sulfate Sodium-Challenge Recovered Mice Prevents Colitis by Promoting the Growth of Lactobacilus reuteri,” Molecular Therapy30, no. 1 (2022): 388-399, https://doi.org/10.1016/j.ymthe.2021.08.025.

[61] S. Liu, R. M. Rezende, T. G. Moreira, et al., “Oral Administration of miR-30d From Feces of MS Patients Suppresses MS-Like Symptoms in Mice by Expanding Akkermansia muciniphila,” Cell Host & Microbe26, no. 6 (2019): 779-794.e8, https://doi.org/10.1016/j.chom.2019.10.008.

[62] Y. Li, Q. Zheng, C. Bao, et al., “Circular RNA Is Enriched and Stable in Exosomes: A Promising Biomarker for Cancer Diagnosis,” Cell Research25, no. 8 (2015): 981-984, https://doi.org/10.1038/cr.2015.82.

[63] H. Shi, S. Huang, M. Qin, et al., “Exosomal circ_0088300 Derived From Cancer-Associated Fibroblasts Acts as a miR-1305 Sponge and Promotes Gastric Carcinoma Cell Tumorigenesis,” Frontiers in Cell and Developmental Biology9 (2021), https://doi.org/10.3389/fcell.2021.676319.

[64] C. Villarroya-Beltri, C. Gutierrez-Vazquez, F. Sanchez-Cabo, et al., “Sumoylated hnRNPA2B1 Controls the Sorting of miRNAs Into Exosomes Through Binding to Specific Motifs,” Nature Communications4, no. 1 (2013): 2980, https://doi.org/10.1038/ncomms3980.

[65] L. Qu, J. Ding, C. Chen, et al., “Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA,” Cancer Cell29, no. 5 (2016): 653-668, https://doi.org/10.1016/j.ccell.2016.03.004.

[66] Z. Pan, R. Zhao, B. Li, et al., “EWSR1-Induced circNEIL3 Promotes Glioma Progression and Exosome-Mediated Macrophage Immunosuppressive Polarization via Stabilizing IGF2BP3,” Molecular Cancer21, no. 1 (2022): 16, https://doi.org/10.1186/s12943-021-01485-6.

[67] Z. Hu, G. Chen, Y. Zhao, et al., “Exosome-Derived circCCAR1 Promotes CD8+T-Cell Dysfunction and Anti-PD1 Resistance in Hepatocellular Carcinoma,” Molecular Cancer22, no. 1 (2023): 55, https://doi.org/10.1186/s12943-023-01759-1.

[68] C. C. Caswell, A. G. Oglesby-Sherrouse, and E. R. Murphy, “Sibling Rivalry: Related Bacterial Small RNAs and Their Redundant and Non-Redundant Roles,” Frontiers in Cellular and Infection Microbiology4 (2014), https://doi.org/10.3389/fcimb.2014.00151.

[69] E. van der Pol, A. N. Boing, P. Harrison, A. Sturk, and R. Nieuwland, “Classification, Functions, and Clinical Relevance of Extracellular Vesicles,” Pharmacological Reviews64, no. 3 (2012): 676-705, https://doi.org/10.1124/pr.112.005983.

[70] M. Yanez-Mo, P. R. Siljander, Z. Andreu, et al., “Biological Properties of Extracellular Vesicles and Their Physiological Functions,” Journal of Extracellular Vesicles4, no. 1 (2015): 27066, https://doi.org/10.3402/jev.v4.27066.

[71] L. Fan, B. Liu, Y. Wang, et al., “Intestinal Lactobacillus Murinus-Derived Small RNAs Target Porcine Polyamine Metabolism,” Proceedings of the National Academy of Sciences of the United States of America121, no. 41 (2024): e1881726175, https://doi.org/10.1073/pnas.2413241121.

[72] R. D. Pathirana and M. Kaparakis-Liaskos, “Bacterial Membrane Vesicles: Biogenesis, Immune Regulation and Pathogenesis,” Cellular Microbiology18, no. 11 (2016): 1518-1524, https://doi.org/10.1111/cmi.12658.

[73] M. Kaparakis-Liaskos and R. L. Ferrero, “Immune Modulation by Bacterial Outer Membrane Vesicles,” Nature Reviews Immunology15, no. 6 (2015): 375-387, https://doi.org/10.1038/nri3837.

[74] S. Dutta, K. I. Iida, A. Takade, Y. Meno, G. B. Nair, and S. Yoshida, “Release of Shiga Toxin by Membrane Vesicles in Shigelia dysenteriae Serotype 1 Strains and In Vitro Effects of Antimicrobials on Toxin Production and Release,” Microbiology and Immunology48, no. 12 (2004): 965-969, https://doi.org/10.1111/j.1348-0421.2004.tb03626.x.

[75] I. A. MacDonald and M. J. Kuehn, “Offense and Defense: Microbial Membrane Vesicles Play Both Ways,” Research in Microbiology163, no. 9–10 (2012): 607-618, https://doi.org/10.1016/j.resmic.2012.10.020.

[76] C. A. Hickey, K. A. Kuhn, D. L. Donermeyer, et al., “Colitogenic Bacteroides Thetaiotaomicron Antigens Access Host Immune Cells in a Sulfatase-Dependent Manner via Outer Membrane Vesicles,” Cell Host & Microbe17, no. 5 (2015): 672-680, https://doi.org/10.1016/j.chom.2015.04.002.

[77] Y. F. Wang and J. Fu, “Secretory and Circulating Bacterial Small RNAs: A Mini-Review of the Literature,” ExRNA1 (2019): 1-5, https://doi.org/10.1186/s41544-019-0015-z.

[78] H. Gu, C. Zhao, T. Zhang, et al., “Salmonella Produce microRNA-Like RNA Fragment Sal-1 in the Infected Cells to Facilitate Intracellular Survival,” Scientific Reports7, no. 1 (2017): 2392, https://doi.org/10.1038/s41598-017-02669-1.

[79] C. Zhao. “ Salmonella Produce microRNA-Like RNA Fragment Sal-1 in the Infected Cells to Facilitate Intracellular Survival via Attenuating iNOS Induction.” 2017.

[80] S. Kreuzer-Redmer, J. C. Bekurtz, D. Arends, et al., “Feeding of Enterococcus Faecium NCIMB 10415 Leads to Intestinal miRNA-423-5p-Induced Regulation of Immune-Relevant Genes,” Applied and Environmental Microbiology82, no. 8 (2016): 2263-2269, https://doi.org/10.1128/aem.04044-15.

[81] Q. Wang, Q. Sun, J. Wang, X. Qiu, R. Qi, and J. Huang, “Lactobacillus Plantarum 299v Changes miRNA Expression in the Intestines of Piglets and Leads to Downregulation of LITAF by Regulating ssc-miR-450a,” Probiotics and Antimicrobial Proteins13, no. 4 (2021): 1093-1105, https://doi.org/10.1007/s12602-021-09743-1.

[82] H. Zhou, L. Yang, J. Ding, et al., “Dynamics of Small Non-Coding RNA Profiles and the Intestinal Microbiome of High and Low Weight Chickens,” Frontiers in Microbiology13 (2022), https://doi.org/10.3389/fmicb.2022.916280.

[83] T. He, J. Ma, S. Liu, et al., “MicroRNA-Microbiota Interactions: Emerging Strategies for Modulating Intestinal Homeostasis and Enhancing Host Health,” iMetaOmicsn/a, no. n/a (2025): e57, https://doi.org/10.1002/imo2.57.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Research and One Health published by John Wiley & Sons Australia, Ltd on behalf of Institute of Animal Science, Chinese Academy of Agricultural Sciences.